0001127602-13-035935.txt : 20131231
0001127602-13-035935.hdr.sgml : 20131231
20131231204811
ACCESSION NUMBER: 0001127602-13-035935
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131231
FILED AS OF DATE: 20131231
DATE AS OF CHANGE: 20131231
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROTHBLATT MARTINE A
CENTRAL INDEX KEY: 0001106578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 131306237
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2013-12-31
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001106578
ROTHBLATT MARTINE A
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
1
1
CEO
Common Stock
2013-12-31
4
S
0
5199
112.5979
D
546035.05
I
By Trusts
Common Stock
2013-12-31
4
S
0
401
113.0423
D
545634.05
I
By Trusts
Common Stock
2013-12-31
4
S
0
292
114.17
D
545342.05
I
By Trusts
Common Stock
2013-12-31
4
S
0
5342
112.5631
D
540000.05
I
By Trusts
Common Stock
2013-12-31
4
S
0
400
113.2925
D
539600.05
I
By Trusts
Common Stock
2013-12-31
4
S
0
1646
112.5483
D
537954.05
I
By Trusts
Common Stock
2013-12-31
4
S
0
200
113.225
D
537754.05
I
By Trusts
Common Stock
2013-12-31
4
S
0
4360
112.5345
D
533394.05
I
By Trusts
Common Stock
2013-12-31
4
S
0
300
113.2367
D
533094.05
I
By Trusts
Common Stock
140
D
Common Stock
166
I
By Spouse
Stock Options
113.08
2013-12-31
4
A
0
1000000
0
A
2013-12-31
2023-12-31
Common Stock
1000000
1000000
D
Shares were sold pursuant to pre-arranged 10b5-1 trading plans entered into by trusts beneficially owned by the reporting person and the reporting person's spouse.
This transaction was executed in multiple trades at prices ranging from $111.9516 to $112.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $112.96 to $113.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $112.11 to $113.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $113.16 to $113.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $112.22 to $112.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $113.11 to $113.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $112.11 to $113.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $113.16 to $113.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Award of stock options in accordance with the terms of the reporting person's employment agreement, which entitles the reporting person to an annual award of stock options to purchase the number of shares of common stock that is equal to one-eighteenth of one percent of the increase (if any) in the issuer's market capitalization from December of the previous year to December of the current year, based on the average closing price of the issuer's common stock during the relevant month.
/s/ John S. Hess, Jr. under Power of Attorney
2013-12-31